Bioactive Lipids: Role in Prostate Cancer Angiogenesis
Abstract
The first objective of phase II of this grant is to delinate the regulation of VEGF gene expression by 12-LOX in PCa cells, specifically the involvement of Sp1 and possibly AP2. The second objective of this proposal is to describe the signal transduction pathway by which 12-LOX stimulates VEGF expression. These two objectives are based upon our observations in the Phase I of this grant that that 12-LOX, when overexpressed in human PCa cells, stimulates tumor angiogenesis and growth. The third objective to evaluate the therapeutic potential of 12-LOX inhibitors for PCa treatment.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2001
- Accession Number
- ADA405532
Entities
People
- Kenneth Honn
Organizations
- Wayne State University